Loading…

Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver

Cyproterone acetate (CPA) is a synthetic steroid which is widely used in antlandrogenic and gestagenic drugs. We have recently shown that CPA induces DNA adducts in cultured rat hepatocytes and in rat liver (1). In the present investigation, we studied the persistence and accumulation of CPA-derived...

Full description

Saved in:
Bibliographic Details
Published in:Carcinogenesis (New York) 1995-10, Vol.16 (10), p.2369-2372
Main Authors: Werner, S., Toplnka, J., Wolff, T., Schwarz, L.R.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c394t-1618e6b53c6c8aa52e840619e874502b051f571ca08216d1ca28a3f92f3d8f73
cites
container_end_page 2372
container_issue 10
container_start_page 2369
container_title Carcinogenesis (New York)
container_volume 16
creator Werner, S.
Toplnka, J.
Wolff, T.
Schwarz, L.R.
description Cyproterone acetate (CPA) is a synthetic steroid which is widely used in antlandrogenic and gestagenic drugs. We have recently shown that CPA induces DNA adducts in cultured rat hepatocytes and in rat liver (1). In the present investigation, we studied the persistence and accumulation of CPA-derived DNA adducts in the liver of rats using the 32 technique. To study the persistence of CPA-DNA adducts, rats were treated with a single oral dose of 10 (female rats) or 100 mg CPA/kg body wt (male rats). Four DNA adducts were detected in the liver of both gender. In female rats, maximal total DNA adduct levels of 3.40±0.04 adducts/106 nucleotides were observed after 1 week. Eleven weeks later, 40% of the adducts determined after 1 week were still detectable. In male rats, maximal hepatic DNA adduct levels of ∼98±3/109 nucleotides were attained after 2 weeks. The adduct level decreased during the following 4 weeks to ∼9;40% of the earlier observed maximal level. To study the accumulation of the CPA-DNA adducts, rats were treated daily with a low oral dose of 50 μg CPA/kg body wt for 42 days. During this treatment period, the level of the four adducts increased continuously from ∼10 to ∼380 adducts/109 nucleotides In the liver of female rats. DNA adducts were formed at much lower levels in male rats; only one type of DNA adduct was detectable, the level of which Increased to ∼6 adducts/10 nucleotides after 42 days. In conclusion, CPA induces DNA adducts in rat liver; binding of the steroid is much higher In female compared to male rats. The CPA-DNA adducts show a high persistence and as a consequence of their long half life, CPA-DNA adducts accumulate significantly in the liver of rats.
doi_str_mv 10.1093/carcin/16.10.2369
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17006828</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17006828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-1618e6b53c6c8aa52e840619e874502b051f571ca08216d1ca28a3f92f3d8f73</originalsourceid><addsrcrecordid>eNo9kEFv1DAQhS0EKkvpD-CA5APiltYTx459XLWUIlVUQntAvVizzkQYss5iOxX770m0qz3NjN-bN9bH2AcQ1yCsvPGYfIg3oOfxupbavmIraLSoajDiNVsJaGQlpWzesnc5_xYCtFT2gl20ymiQ7YrR2vtpNw1Ywhg5xo7vKeWQC0VPfOz53fc1x66bfMnLWH4Rz4c4lxI8n21pDB33h30alz4SR08FC_EQecLCh_BC6T170-OQ6epUL9nm_svm9qF6fPr67Xb9WHlpm1KBBkN6q6TX3iCqmkwjNFgybaNEvRUKetWCR2Fq0N3c1AZlb-tedqZv5SX7fIydf_N3olzcLmRPw4CRxik7aIXQpjazEY5Gn8acE_Vun8IO08GBcAtZdyTrQC8vC9l55-MpfNruqDtvnFDO-qeTjtnj0CeMPuSzbY6w0iynq6NtYfzvLGP643QrW-Uefj47q2yzUfc_nJb_AWgakcc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17006828</pqid></control><display><type>article</type><title>Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Werner, S. ; Toplnka, J. ; Wolff, T. ; Schwarz, L.R.</creator><creatorcontrib>Werner, S. ; Toplnka, J. ; Wolff, T. ; Schwarz, L.R.</creatorcontrib><description>Cyproterone acetate (CPA) is a synthetic steroid which is widely used in antlandrogenic and gestagenic drugs. We have recently shown that CPA induces DNA adducts in cultured rat hepatocytes and in rat liver (1). In the present investigation, we studied the persistence and accumulation of CPA-derived DNA adducts in the liver of rats using the 32 technique. To study the persistence of CPA-DNA adducts, rats were treated with a single oral dose of 10 (female rats) or 100 mg CPA/kg body wt (male rats). Four DNA adducts were detected in the liver of both gender. In female rats, maximal total DNA adduct levels of 3.40±0.04 adducts/106 nucleotides were observed after 1 week. Eleven weeks later, 40% of the adducts determined after 1 week were still detectable. In male rats, maximal hepatic DNA adduct levels of ∼98±3/109 nucleotides were attained after 2 weeks. The adduct level decreased during the following 4 weeks to ∼9;40% of the earlier observed maximal level. To study the accumulation of the CPA-DNA adducts, rats were treated daily with a low oral dose of 50 μg CPA/kg body wt for 42 days. During this treatment period, the level of the four adducts increased continuously from ∼10 to ∼380 adducts/109 nucleotides In the liver of female rats. DNA adducts were formed at much lower levels in male rats; only one type of DNA adduct was detectable, the level of which Increased to ∼6 adducts/10 nucleotides after 42 days. In conclusion, CPA induces DNA adducts in rat liver; binding of the steroid is much higher In female compared to male rats. The CPA-DNA adducts show a high persistence and as a consequence of their long half life, CPA-DNA adducts accumulate significantly in the liver of rats.</description><identifier>ISSN: 0143-3334</identifier><identifier>EISSN: 1460-2180</identifier><identifier>DOI: 10.1093/carcin/16.10.2369</identifier><identifier>PMID: 7586137</identifier><identifier>CODEN: CRNGDP</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Androgen Antagonists - metabolism ; Animals ; Autoradiography ; Biological and medical sciences ; Cells, Cultured ; Cyproterone Acetate - metabolism ; DNA Adducts - isolation &amp; purification ; DNA Adducts - metabolism ; Drug toxicity and drugs side effects treatment ; Female ; Kinetics ; Liver - metabolism ; Male ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Phosphorus Radioisotopes ; Rats ; Rats, Wistar ; Time Factors</subject><ispartof>Carcinogenesis (New York), 1995-10, Vol.16 (10), p.2369-2372</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-1618e6b53c6c8aa52e840619e874502b051f571ca08216d1ca28a3f92f3d8f73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3699388$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7586137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Werner, S.</creatorcontrib><creatorcontrib>Toplnka, J.</creatorcontrib><creatorcontrib>Wolff, T.</creatorcontrib><creatorcontrib>Schwarz, L.R.</creatorcontrib><title>Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver</title><title>Carcinogenesis (New York)</title><addtitle>Carcinogenesis</addtitle><description>Cyproterone acetate (CPA) is a synthetic steroid which is widely used in antlandrogenic and gestagenic drugs. We have recently shown that CPA induces DNA adducts in cultured rat hepatocytes and in rat liver (1). In the present investigation, we studied the persistence and accumulation of CPA-derived DNA adducts in the liver of rats using the 32 technique. To study the persistence of CPA-DNA adducts, rats were treated with a single oral dose of 10 (female rats) or 100 mg CPA/kg body wt (male rats). Four DNA adducts were detected in the liver of both gender. In female rats, maximal total DNA adduct levels of 3.40±0.04 adducts/106 nucleotides were observed after 1 week. Eleven weeks later, 40% of the adducts determined after 1 week were still detectable. In male rats, maximal hepatic DNA adduct levels of ∼98±3/109 nucleotides were attained after 2 weeks. The adduct level decreased during the following 4 weeks to ∼9;40% of the earlier observed maximal level. To study the accumulation of the CPA-DNA adducts, rats were treated daily with a low oral dose of 50 μg CPA/kg body wt for 42 days. During this treatment period, the level of the four adducts increased continuously from ∼10 to ∼380 adducts/109 nucleotides In the liver of female rats. DNA adducts were formed at much lower levels in male rats; only one type of DNA adduct was detectable, the level of which Increased to ∼6 adducts/10 nucleotides after 42 days. In conclusion, CPA induces DNA adducts in rat liver; binding of the steroid is much higher In female compared to male rats. The CPA-DNA adducts show a high persistence and as a consequence of their long half life, CPA-DNA adducts accumulate significantly in the liver of rats.</description><subject>Androgen Antagonists - metabolism</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Cyproterone Acetate - metabolism</subject><subject>DNA Adducts - isolation &amp; purification</subject><subject>DNA Adducts - metabolism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Kinetics</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorus Radioisotopes</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Time Factors</subject><issn>0143-3334</issn><issn>1460-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNo9kEFv1DAQhS0EKkvpD-CA5APiltYTx459XLWUIlVUQntAvVizzkQYss5iOxX770m0qz3NjN-bN9bH2AcQ1yCsvPGYfIg3oOfxupbavmIraLSoajDiNVsJaGQlpWzesnc5_xYCtFT2gl20ymiQ7YrR2vtpNw1Ywhg5xo7vKeWQC0VPfOz53fc1x66bfMnLWH4Rz4c4lxI8n21pDB33h30alz4SR08FC_EQecLCh_BC6T170-OQ6epUL9nm_svm9qF6fPr67Xb9WHlpm1KBBkN6q6TX3iCqmkwjNFgybaNEvRUKetWCR2Fq0N3c1AZlb-tedqZv5SX7fIydf_N3olzcLmRPw4CRxik7aIXQpjazEY5Gn8acE_Vun8IO08GBcAtZdyTrQC8vC9l55-MpfNruqDtvnFDO-qeTjtnj0CeMPuSzbY6w0iynq6NtYfzvLGP643QrW-Uefj47q2yzUfc_nJb_AWgakcc</recordid><startdate>19951001</startdate><enddate>19951001</enddate><creator>Werner, S.</creator><creator>Toplnka, J.</creator><creator>Wolff, T.</creator><creator>Schwarz, L.R.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19951001</creationdate><title>Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver</title><author>Werner, S. ; Toplnka, J. ; Wolff, T. ; Schwarz, L.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-1618e6b53c6c8aa52e840619e874502b051f571ca08216d1ca28a3f92f3d8f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Androgen Antagonists - metabolism</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Cyproterone Acetate - metabolism</topic><topic>DNA Adducts - isolation &amp; purification</topic><topic>DNA Adducts - metabolism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Kinetics</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorus Radioisotopes</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Werner, S.</creatorcontrib><creatorcontrib>Toplnka, J.</creatorcontrib><creatorcontrib>Wolff, T.</creatorcontrib><creatorcontrib>Schwarz, L.R.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Carcinogenesis (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Werner, S.</au><au>Toplnka, J.</au><au>Wolff, T.</au><au>Schwarz, L.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver</atitle><jtitle>Carcinogenesis (New York)</jtitle><addtitle>Carcinogenesis</addtitle><date>1995-10-01</date><risdate>1995</risdate><volume>16</volume><issue>10</issue><spage>2369</spage><epage>2372</epage><pages>2369-2372</pages><issn>0143-3334</issn><eissn>1460-2180</eissn><coden>CRNGDP</coden><abstract>Cyproterone acetate (CPA) is a synthetic steroid which is widely used in antlandrogenic and gestagenic drugs. We have recently shown that CPA induces DNA adducts in cultured rat hepatocytes and in rat liver (1). In the present investigation, we studied the persistence and accumulation of CPA-derived DNA adducts in the liver of rats using the 32 technique. To study the persistence of CPA-DNA adducts, rats were treated with a single oral dose of 10 (female rats) or 100 mg CPA/kg body wt (male rats). Four DNA adducts were detected in the liver of both gender. In female rats, maximal total DNA adduct levels of 3.40±0.04 adducts/106 nucleotides were observed after 1 week. Eleven weeks later, 40% of the adducts determined after 1 week were still detectable. In male rats, maximal hepatic DNA adduct levels of ∼98±3/109 nucleotides were attained after 2 weeks. The adduct level decreased during the following 4 weeks to ∼9;40% of the earlier observed maximal level. To study the accumulation of the CPA-DNA adducts, rats were treated daily with a low oral dose of 50 μg CPA/kg body wt for 42 days. During this treatment period, the level of the four adducts increased continuously from ∼10 to ∼380 adducts/109 nucleotides In the liver of female rats. DNA adducts were formed at much lower levels in male rats; only one type of DNA adduct was detectable, the level of which Increased to ∼6 adducts/10 nucleotides after 42 days. In conclusion, CPA induces DNA adducts in rat liver; binding of the steroid is much higher In female compared to male rats. The CPA-DNA adducts show a high persistence and as a consequence of their long half life, CPA-DNA adducts accumulate significantly in the liver of rats.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>7586137</pmid><doi>10.1093/carcin/16.10.2369</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-3334
ispartof Carcinogenesis (New York), 1995-10, Vol.16 (10), p.2369-2372
issn 0143-3334
1460-2180
language eng
recordid cdi_proquest_miscellaneous_17006828
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Androgen Antagonists - metabolism
Animals
Autoradiography
Biological and medical sciences
Cells, Cultured
Cyproterone Acetate - metabolism
DNA Adducts - isolation & purification
DNA Adducts - metabolism
Drug toxicity and drugs side effects treatment
Female
Kinetics
Liver - metabolism
Male
Medical sciences
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Phosphorus Radioisotopes
Rats
Rats, Wistar
Time Factors
title Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A29%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accumulation%20and%20persistence%20of%20DNA%20adducts%20of%20the%20synthetic%20steroid%20cyproterone%20acetate%20in%20rat%20liver&rft.jtitle=Carcinogenesis%20(New%20York)&rft.au=Werner,%20S.&rft.date=1995-10-01&rft.volume=16&rft.issue=10&rft.spage=2369&rft.epage=2372&rft.pages=2369-2372&rft.issn=0143-3334&rft.eissn=1460-2180&rft.coden=CRNGDP&rft_id=info:doi/10.1093/carcin/16.10.2369&rft_dat=%3Cproquest_cross%3E17006828%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c394t-1618e6b53c6c8aa52e840619e874502b051f571ca08216d1ca28a3f92f3d8f73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17006828&rft_id=info:pmid/7586137&rfr_iscdi=true